Collection: Other disorders of the skin and subcutaneous tissue
-
Clinical Endpoints Study for STURGE-WEBER SYNDROME
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for XANTHOGRANULOMA JUVENILE
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for STURGE-WEBER SYNDROME
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for PAPILLON LEFEVRE DISEASE
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for LUPUS ERYTHEMATOSUS, CUTANEOUS
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for APLASIA CUTIS CONGENITA
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for SKIN HEMOSIDEROSIS
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for TOXIC EPIDERMAL NECROLYSIS
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for PILOMATRIXOMA
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for MORPHEA
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for DEGOS DISEASE
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for SWEET'S SYNDROME
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for LINEAR SCLERODERMA
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for NEVUS OF OTA
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for ACROCYANOSIS
Regular price From €2.000,00 EURRegular priceUnit price / per -
Clinical Endpoints Study for FABRY DISEASE
Regular price From €2.000,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...